DMGV Is a Rheostat of T Cell Survival and a Potential Therapeutic for Inflammatory Diseases and Cancers

Activated effector T cells (Teff) and/or compromised regulatory T cells (Treg) underlie many chronic inflammatory diseases. We discovered a novel pathway to regulate survival and expansion of Teff without compromising Treg survival and a potential therapeutic to treat these diseases. We found dimeth...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fengyuan Mandy, Shen, Liya, Fan, Dengxia Denise, Chen, Kuan-Hung, Lee, Jongdae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389583/
https://www.ncbi.nlm.nih.gov/pubmed/35990633
http://dx.doi.org/10.3389/fimmu.2022.918241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389583/
https://www.ncbi.nlm.nih.gov/pubmed/35990633
http://dx.doi.org/10.3389/fimmu.2022.918241

Ejemplares similares